Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
  Division of Sexually Transmitted Diseases
    Program and Training Branch
STD Prevention STD Training Home Links Contact Us Glossary 
STD Prevention
Self-Study Modules
Syphilis
Course Objective
Line separator
Target audience
Line separator
Continuing education
Lessons
Line separator
Epidemiology
Line separator
Pathogenesis and microbiology
Line separator
Clinical manifestations and sequelae
Line separator
Diagnostic methods
Line separator
Patient management / treatment
Line separator
Patient counseling and education
Line separator
Partner management / Public health
Line separator
Case study
Line separator
Resources
Line separator
 
 
 

Self-Study STD Module - Syphilis

Patient Management/Treatment

Treatment Regimens

The following are 2006 CDC-recommended treatment regimens for syphilis. Refer to the 2006 CDC STD Treatment Guidelines for additional and more detailed information. Penicillin G, administered parenterally, is the preferred drug for treatment of all stages of syphilis. The preparation(s) used (i.e., benzathine, aqueous procaine, or aqueous crystalline), the dosage, and the length of treatment depend on the stage and clinical manifestations of the disease. However, neither combinations of benzathine penicillin and procaine penicillin nor oral penicillin preparations are considered appropriate for the treatment of syphilis. Reports have indicated that inappropriate use of combination benzathine-procaine penicillin (Bicillin C-R®) instead of the standard benzathine penicillin product widely used in the United States (Bicillin L-A®) has occurred. Practitioners, pharmacists, and purchasing agents should be aware of the similar names of these two products and avoid use of the inappropriate combination therapy agent for treating syphilis.

Adults
Primary, secondary, and early latent syphilis without neurologic involvement:

Benzathine penicillin G, IM, 2.4 million units in a single dose

     If penicillin allergic (one of the following):
          Doxycycline 100 mg orally twice daily for 2 weeks
          Tetracycline 500 mg orally 4 times daily for 2 weeks

Late latent or latent syphilis of unknown duration without neurologic involvement:

Benzathine penicillin G 7.2 million units total, administered as three doses of 2.4 million units IM each at 1-week intervals

     If penicillin allergic (one of the following):
          Doxycycline 100 mg orally twice daily for 28 days
          Tetracycline 500 mg orally 4 times daily for 28 days

Tertiary (late) syphilis without neurologic involvement:

Benzathine penicillin G 7.2 million units total, administered as three doses of 2.4 million units IM each at 1-week intervals

     If penicillin allergic:
          Treat according to treatment for late latent syphilis.

Neurosyphilis:

Aqueous crystalline penicillin G 18-24 million units per day, administered as 3-4 million units IV every 4 hours or continuous infusion for 10-14 days IV
 
Alternative regimen (if compliance can be ensured):
  Procaine penicillin 2.4 million units IM once daily
PLUS
Probenecid 500 mg orally 4 times a day, both for 10-14 days
 
 
Page 12 of 19 BackStatusStatusNext
Page last modified: June 3, 2009
Page last reviewed: June 3, 2009

Content Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 


STD Home
| STD Index

CDC Home | Search | Health Topics A-Z

Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
     Division of Sexually Transmitted Diseases Prevention